NTI | bio convened more than 30 experts for a meeting of the Biosecurity Innovation and Risk Reduction Initiative (BIRRI) in London, United Kingdom between June 9-10, 2022.
Experts from NTI’s Nuclear Materials Security program joined more than 50 participants from 19 countries at Egmont Palace in Brussels, Belgium from June 27-29, 2022, to support the International Partnership for Disarmament Verification’s (IPNDV) first in-person meeting in more than two years.
This paper offers a focused set of recommendations for specific commitments related to practical and achievable actions that States parties to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT) could take to advance the NPT’s goals and achieve success at the 10th NPT Review Conference.
The Technical Consortium for DNA Synthesis Screening, convened by NTI | bio and the World Economic Forum (WEF), responded to the U.S. government’s request for comment on its Revised Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides.
Richard Johnson on the importance of diversity in the national security space and his advice for young people interested in the field.
NTI | bio team members join hundreds of global health security experts from around the world in Singapore for the second Global Health Security Conference.
Nicholas Cropper, Shrestha Rath, and Ryan Teo are the winners of the Sixth Annual Next Generation for Biosecurity Competition.
Eric Brewer calls on Washington to improve its ability to detect and respond to Iran’s nuclear activities now that its nuclear program enters “dangerous new territory” with enough highly enriched uranium for a nuclear bomb.
The Nuclear Threat Initiative (NTI) convened the fifteenth meeting of the Global Dialogue on Nuclear Security Priorities in Hiroshima, Japan from June 8-10, 2022.
NTI and the Vienna Center for Disarmament and Nonproliferation (VCDNP) co-hosted a meeting on June 7, 2022 to explore the possibility of establishing a new “Joint Assessment Mechanism” to strengthen UN-system capabilities to investigate high-consequence biological events of unknown origin.
Sign up for regular updates on innovative, real-world solutions to existential threats.
